share_log

Fresh Tracks Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Stephen L. Gustin(21.3%),Exploration Capital, LLC(20.5%)

Fresh Tracks Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Stephen L. Gustin(21.3%),Exploration Capital, LLC(20.5%)

Fresh Tracks Therapeutics | SC 13D:超过5%持股股东披露文件-Stephen L. Gustin(21.3%),Exploration Capital, LLC(20.5%)
美股sec公告 ·  05/08 16:06
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息